Michael Case, MS
- 6Articles
- 24.1KReads
- 2005–2011Active
- 23Collaborators
- 95Citations
About
Michael Case, MS, has contributed extensively to research on treatment-resistant depression and bipolar disorder, focusing on pharmacological approaches involving olanzapine and fluoxetine. His work includes analyses of combination therapies, their efficacy, and associated side effects such as weight gain. Between 2005 and 2011, he published studies assessing treatment algorithms and the management of treatment-emergent mania. His research often involved collaboration with noted co-authors in clinical psychiatry.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
